Key result
Early nonfatal TAVI complications are linked to ~114% higher 1-year mortality among 30-day survivors.
Why the study?
The impact of early nonfatal complications on subsequent mortality and quality of life after contemporary TAVI remains unclear.
Does the occurrence of early nonfatal complications after TAVI increase 1-year mortality in patients with severe aortic stenosis?
Cohort (n=742)
Open-label
Yes
Does the occurrence of early nonfatal complications after TAVI increase 1-year mortality in patients with severe aortic stenosis?
Early nonfatal complications after TAVI are associated with a twofold increased risk of 1-year mortality, highlighting the need for procedural optimization to prevent these events.
Answers are grounded in this paper and cite their sources.
May warrant closer surveillance after TAVI; observational data leave open whether preventing complications improves survival.
Background: The impact of early nonfatal complications on subsequent mortality and quality of life (QOL) after contemporary transcatheter aortic valve implantation (TAVI) remains unclear. Methods: This post-hoc substudy of the LANDMARK trial included patients with severe aortic stenosis randomized to the Myval transcatheter heart valve (THV) series or to contemporary THV (Sapien or Evolut) series. Early nonfatal complications were defined as events occurring within 30 days after TAVI in patients surviving the first 30 days and included stroke, type 3 bleeding, major vascular complications, acute kidney injury stages 2-4, moderate or severe aortic regurgitation, new permanent pacemaker implantation, or reintervention according to the VARC-3 early safety endpoint. The primary endpoint was all-cause mortality from 30 to 365 days. QOL was assessed using the Short Form-12 at baseline, 30 days, and 1 year. One-year QOL did not differ between groups. Conclusions: In this post-hoc, hypothesis-generating analysis, early nonfatal complications after TAVI were associated with increased 1-year mortality, whereas 1-year QOL was comparable among survivors; findings should be interpreted with caution due to potential survivor bias. Trial registration number: ClinicalTrials.gov, NCT04275726.
No takes yet. Share an insight, caveat, or question.
Tobe et al. (2026) conducted a cohort in Severe aortic stenosis (n=742). Early nonfatal complications vs. No early nonfatal complications was evaluated on All-cause mortality from 30 to 365 days (HR 2.14, 95% CI 1.07-4.27, p=0.03). Early nonfatal complications within 30 days after transcatheter aortic valve implantation were independently associated with increased 1-year mortality among 30-day survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: